giona easyhaler 200 mikrog/ dose
orion corporation - espoo - budesonid - inhalasjonspulver - 200 mikrog/ dose
yellox 0.9 mg/ ml
2care4 aps - bromfenaknatriumsesquihydrat - Øyedråper, oppløsning - 0.9 mg/ ml
dexdomitor 0.5 mg/ ml
orifarm as - deksmedetomidin - injeksjonsvæske, oppløsning - 0.5 mg/ ml
rhinox 0.25 mg/ ml
orifarm healthcare a/s - oksymetazolinhydroklorid - nesespray, oppløsning - 0.25 mg/ ml
rhinox 0.5 mg/ ml
orifarm healthcare a/s - oksymetazolinhydroklorid - nesespray, oppløsning - 0.5 mg/ ml
somac 40 mg
takeda as - pantoprazolnatriumsesquihydrat - pulver til injeksjonsvæske, oppløsning - 40 mg
zycomb 0.5 mg/ ml / 0.6 mg/ ml
orifarm healthcare a/s - xylometazolinhydroklorid / ipratropiumbromid - nesespray, oppløsning - 0.5 mg/ ml / 0.6 mg/ ml
zymelin 1 mg/ ml
orifarm healthcare a/s - xylometazolinhydroklorid - nesespray, oppløsning - 1 mg/ ml
zymelin 0.5 mg/ ml
orifarm healthcare a/s - xylometazolinhydroklorid - nesespray, oppløsning - 0.5 mg/ ml
tecovirimat siga
siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - antivirale midler til systemisk bruk - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 og 5. tecovirimat siga should be used in accordance with official recommendations.